104 related articles for article (PubMed ID: 17580408)
1. Aspirin is lifesaving for cancer patients with ACS. Benefits of aspirin treatment for patients with acute coronary syndrome are immediate.
Duke Med Health News; 2007 May; 13(5):8-9. PubMed ID: 17580408
[No Abstract] [Full Text] [Related]
2. Pharmacological treatment of acute coronary syndromes.
Hughes K
Prof Nurse; 2003 Jan; 18(5):296-9. PubMed ID: 12599964
[TBL] [Abstract][Full Text] [Related]
3. [Combination is standard. Dual thrombocyte function inhibition in acute coronary syndrome].
MMW Fortschr Med; 2004; 146 Suppl 1():8-9. PubMed ID: 15493411
[No Abstract] [Full Text] [Related]
4. [Acute coronary syndrome. The second platelet inhibitor is self-paid].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866304
[No Abstract] [Full Text] [Related]
5. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
Peters RJ; Mehta SR; Fox KA; Zhao F; Lewis BS; Kopecky SL; Diaz R; Commerford PJ; Valentin V; Yusuf S;
Circulation; 2003 Oct; 108(14):1682-7. PubMed ID: 14504182
[TBL] [Abstract][Full Text] [Related]
6. Contemporary view of the acute coronary syndromes.
Moustapha A; Anderson HV
J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619
[No Abstract] [Full Text] [Related]
7. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.
Chin CT; Roe MT; Fox KA; Prabhakaran D; Marshall DA; Petitjean H; Lokhnygina Y; Brown E; Armstrong PW; White HD; Ohman EM;
Am Heart J; 2010 Jul; 160(1):16-22.e1. PubMed ID: 20598967
[TBL] [Abstract][Full Text] [Related]
8. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
Mehta SR; Yusuf S;
Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
[TBL] [Abstract][Full Text] [Related]
9. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes.
Rieckmann N; Kronish IM; Haas D; Gerin W; Chaplin WF; Burg MM; Vorchheimer D; Davidson KW
Am Heart J; 2006 Nov; 152(5):922-7. PubMed ID: 17070160
[TBL] [Abstract][Full Text] [Related]
10. [Antiplatelet therapy in acute coronary syndromes without ST segment elevation].
Umman B
Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():13-9. PubMed ID: 16613770
[TBL] [Abstract][Full Text] [Related]
11. [Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?].
Rupprecht HJ
MMW Fortschr Med; 2004; 146 Suppl 1():9-10. PubMed ID: 15493412
[No Abstract] [Full Text] [Related]
12. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
Lim MJ; Spencer FA; Gore JM; Dabbous OH; Agnelli G; Kline-Rogers EM; Dibenedetto D; Eagle KA; Mehta RH;
Eur Heart J; 2005 Jun; 26(11):1063-9. PubMed ID: 15716281
[TBL] [Abstract][Full Text] [Related]
13. Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin.
Santopinto J; Gurfinkel EP; Torres V; Marcos E; Bozovich GE; Mautner B; McCabe CH; Antman EM
Am Heart J; 2001 Apr; 141(4):566-72. PubMed ID: 11275921
[TBL] [Abstract][Full Text] [Related]
14. Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes.
Cavendish JJ; Fugit RV; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1839-43. PubMed ID: 15537484
[TBL] [Abstract][Full Text] [Related]
15. [The use of acetylsalicylic acid in IHD].
Lenkovsky F; Neirinck LG; Glezer SV
Ter Arkh; 1996; 68(8):79-83. PubMed ID: 9019841
[No Abstract] [Full Text] [Related]
16. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.
Andreotti F; Testa L; Biondi-Zoccai GG; Crea F
Eur Heart J; 2006 Mar; 27(5):519-26. PubMed ID: 16143706
[TBL] [Abstract][Full Text] [Related]
17. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications].
Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H
Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202
[TBL] [Abstract][Full Text] [Related]
18. [Angina at rest as an alarm syndrome. Progress in treatment of acute coronary syndrome].
Stiefelhagen P
MMW Fortschr Med; 1999 Jul; 141(28-29):35-7. PubMed ID: 10897940
[No Abstract] [Full Text] [Related]
19. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
[TBL] [Abstract][Full Text] [Related]
20. Weighing benefits and risks--the FDA's review of prasugrel.
Unger EF
N Engl J Med; 2009 Sep; 361(10):942-5. PubMed ID: 19726770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
